Varenicline induced acute interstitial nephritis in the setting of idiopathic membranous glomerulonephritis
Open Access
- 11 November 2013
- journal article
- case report
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 248
Abstract
Varenicline is a nicotinic receptor partial agonist indicated for the cessation of smoking. It is regarded as having no or minimal renal toxicity. A single case report has linked it to acute interstitial nephritis.Keywords
This publication has 20 references indexed in Scilit:
- Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysisCanadian Medical Association Journal, 2011
- Treatment of nicotine addiction: present therapeutic options and pipeline developmentsTrends in Pharmacological Sciences, 2011
- Drug-induced acute interstitial nephritisNature Reviews Nephrology, 2010
- Acute interstitial nephritisKidney International, 2010
- Population pharmacokinetic analysis of varenicline in adult smokersBritish Journal of Clinical Pharmacology, 2009
- Does Varenicline Induce Acute Interstitial Nephritis?Mayo Clinic Proceedings, 2009
- Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritisKidney International, 2008
- Mycophenolate Mofetil for the Treatment of Interstitial NephritisClinical Journal of the American Society of Nephrology, 2006
- Drug-induced acute interstitial nephritisKidney International, 2001
- Acute Interstitial Nephritis: A Clinical and Morphological Study in 27 PatientsNephrology Dialysis Transplantation, 1990